Are you under-prescribing nicotine? Before you respond with “WTF?” (What’s This Foolishness?), please take a moment to consider this: the potential therapeutic use of nicotine has been an ongoing question for medical research since 1926. Investigations as to nicotine’s use to treat neurodegenerative conditions like Alzheimer’s, Parkinson’s, Mild Cognitive Impairment as well as neuropsychiatric conditions like ADHD, schizophrenia, autism, depressions, Down’s Syndrome, and chemobrain has been going on for years without receiving much attention in the medical community.
You are invited to spend an evening with one of the world’s leading experts on the clinical use of nicotine in order to educate yourself about a potential new tool for your therapeutic toolkit.
Our guide for the evening will be Dr. Paul A. Newhouse, Director of the Center for Cognitive Medicine in the Department of Psychiatry at Vanderbilt University Medical Center. He is also Jim Turner Professor of Cognitive Disorders at Vanderbilt University School of Medicine and Professor of Psychiatry, Pharmacology, and Medicine.
World No Tobacco Day is May 31, a day dedicated to raising awareness of the dangers of smoking. Please join us a few days before that to consider the benefits of nicotine and the risks of throwing out the baby with the bathwater.
No comments:
Post a Comment